A detailed history of Financial Advocates Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Advocates Investment Management holds 17,749 shares of NVO stock, worth $1.55 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
17,749
Previous 17,739 0.06%
Holding current value
$1.55 Million
Previous $2.53 Million 16.55%
% of portfolio
0.12%
Previous 0.16%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$119.07 - $145.42 $1,190 - $1,454
10 Added 0.06%
17,749 $2.11 Million
Q2 2024

Jul 26, 2024

SELL
$122.71 - $146.91 $677,604 - $811,237
-5,522 Reduced 23.74%
17,739 $2.53 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $22,668 - $30,174
222 Added 0.96%
23,261 $2.99 Million
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $26,685 - $32,056
-304 Reduced 1.3%
23,039 $2.38 Million
Q3 2023

Oct 27, 2023

BUY
$90.94 - $199.54 $1.33 Million - $2.91 Million
14,579 Added 166.35%
23,343 $2.12 Million
Q2 2023

Aug 07, 2023

BUY
$155.98 - $172.65 $62,703 - $69,405
402 Added 4.81%
8,764 $1.42 Million
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $91,049 - $109,488
688 Added 8.97%
8,362 $1.33 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $405,892 - $535,636
3,958 Added 106.51%
7,674 $1.04 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $352,821 - $432,991
-3,703 Reduced 49.91%
3,716 $560,000
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $151,659 - $178,938
1,469 Added 24.69%
7,419 $826,000
Q1 2022

May 11, 2022

BUY
$93.1 - $112.54 $255,931 - $309,372
2,749 Added 85.88%
5,950 $660,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $5,273 - $6,439
-55 Reduced 1.69%
3,201 $358,000
Q3 2021

Nov 04, 2021

BUY
$84.42 - $106.62 $274,871 - $347,154
3,256 New
3,256 $312,000
Q3 2020

Nov 04, 2020

SELL
$63.69 - $70.22 $208,903 - $230,321
-3,280 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $192,011 - $222,843
3,280 New
3,280 $215,000
Q3 2019

Nov 13, 2019

SELL
$47.54 - $53.43 $272,023 - $305,726
-5,722 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$46.79 - $52.47 $9,217 - $10,336
-197 Reduced 3.33%
5,722 $292,000
Q1 2019

May 16, 2019

SELL
$46.36 - $52.63 $6,954 - $7,894
-150 Reduced 2.47%
5,919 $310,000
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $9,720 - $11,056
-234 Reduced 3.71%
6,069 $279,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $3,647 - $3,996
78 Added 1.25%
6,303 $0
Q2 2018

Aug 09, 2018

BUY
$44.29 - $50.42 $6,510 - $7,411
147 Added 2.42%
6,225 $291,000
Q1 2018

May 11, 2018

BUY
$48.49 - $58.14 $290 - $348
6 Added 0.1%
6,078 $300,000
Q4 2017

Feb 15, 2018

BUY
$47.53 - $53.73 $288,602 - $326,248
6,072
6,072 $326,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.